ZURICH, July 19 (Reuters) – Switzerland’s Novartis,
the world’s biggest maker of prescription drugs, will continue
to invest in Britain, despite the country’s decision to leave
the European Union,…
The post Novartis, world’s top drugmaker, plays down Brexit threat appeared first on NASDAQ.